Aberdeen Wealth Management LLC Sells 145 Shares of The Procter & Gamble Company (NYSE:PG)

Aberdeen Wealth Management LLC lessened its stake in The Procter & Gamble Company (NYSE:PG) by 1.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,256 shares of the company’s stock after selling 145 shares during the period. Procter & Gamble comprises 0.9% of Aberdeen Wealth Management LLC’s portfolio, making the stock its 26th biggest holding. Aberdeen Wealth Management LLC’s holdings in Procter & Gamble were worth $1,430,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in PG. Itau Unibanco Holding S.A. acquired a new position in Procter & Gamble in the second quarter worth about $28,000. Fairway Wealth LLC acquired a new position in Procter & Gamble during the second quarter worth $29,000. POM Investment Strategies LLC bought a new position in shares of Procter & Gamble during the second quarter valued at $34,000. Quest Partners LLC acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at $36,000. Finally, Fairfield Financial Advisors LTD acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth about $44,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Up 0.7 %

NYSE:PG opened at $170.80 on Tuesday. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The stock’s fifty day simple moving average is $170.21 and its 200-day simple moving average is $168.45. The firm has a market capitalization of $402.24 billion, a P/E ratio of 29.45, a P/E/G ratio of 3.67 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter last year, the firm earned $1.83 EPS. Procter & Gamble’s quarterly revenue was down .6% compared to the same quarter last year. Equities research analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.36%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Insiders Place Their Bets

In other news, CEO Jon R. Moeller sold 37,240 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total value of $6,289,463.60. Following the sale, the chief executive officer now directly owns 263,537 shares in the company, valued at $44,508,763.93. This trade represents a 12.38 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the transaction, the chief executive officer now owns 13,721 shares of the company’s stock, valued at $2,332,570. The trade was a 87.49 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 270,727 shares of company stock worth $46,014,037. Company insiders own 0.18% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on PG. Evercore ISI upped their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Stifel Nicolaus increased their price target on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research report on Monday, July 22nd. JPMorgan Chase & Co. raised their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Morgan Stanley boosted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Finally, Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price for the company. in a research note on Monday, September 30th. Nine investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.